This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2003 May;52(5):338-41.

doi: 10.1007/s00262-002-0353-8. Epub 2003 Mar 6.

Immunotoxins containing Pseudomonas exotoxin A: a short history

Ira Pastan¹

Affiliations

Affiliation

¹ Laboratory of Molecular Biology, Center for Cancer Research, National Cancer Institute, 37 Convent Drive, Room 5106, Bethesda, MD 20892-4268, USA. pastani@pop.nci.nih.gov

PMID: 12700949
PMCID: PMC11032809
DOI: 10.1007/s00262-002-0353-8

Review

Immunotoxins containing Pseudomonas exotoxin A: a short history

Ira Pastan. Cancer Immunol Immunother. 2003 May.

. 2003 May;52(5):338-41.

doi: 10.1007/s00262-002-0353-8. Epub 2003 Mar 6.

Author

Ira Pastan¹

Affiliation

¹ Laboratory of Molecular Biology, Center for Cancer Research, National Cancer Institute, 37 Convent Drive, Room 5106, Bethesda, MD 20892-4268, USA. pastani@pop.nci.nih.gov

PMID: 12700949
PMCID: PMC11032809
DOI: 10.1007/s00262-002-0353-8

No abstract available

PubMed Disclaimer

Similar articles

A guide to taming a toxin--recombinant immunotoxins constructed from Pseudomonas exotoxin A for the treatment of cancer.
Weldon JE, Pastan I. Weldon JE, et al. FEBS J. 2011 Dec;278(23):4683-700. doi: 10.1111/j.1742-4658.2011.08182.x. Epub 2011 Jun 2. FEBS J. 2011. PMID: 21585657 Free PMC article. Review.
Mechanisms of Resistance to Immunotoxins Containing Pseudomonas Exotoxin A in Cancer Therapy.
Dieffenbach M, Pastan I. Dieffenbach M, et al. Biomolecules. 2020 Jun 30;10(7):979. doi: 10.3390/biom10070979. Biomolecules. 2020. PMID: 32630017 Free PMC article. Review.
Immunogenicity of therapeutic recombinant immunotoxins.
Mazor R, Onda M, Pastan I. Mazor R, et al. Immunol Rev. 2016 Mar;270(1):152-64. doi: 10.1111/imr.12390. Immunol Rev. 2016. PMID: 26864110 Free PMC article. Review.
Is Pseudomonas aeruginosa exotoxin A a good carrier protein for conjugate vaccines?
Pier GB. Pier GB. Hum Vaccin. 2007 Mar-Apr;3(2):39-40; author reply 41. doi: 10.4161/hv.3.2.3715. Epub 2007 Mar 8. Hum Vaccin. 2007. PMID: 17268204 No abstract available.
Human kappa light chain targeted Pseudomonas exotoxin A--identifying human antibodies and Fab fragments with favorable characteristics for antibody-drug conjugate development.
Kellner C, Bleeker WK, Lammerts van Bueren JJ, Staudinger M, Klausz K, Derer S, Glorius P, Muskulus A, de Goeij BE, van de Winkel JG, Parren PW, Valerius T, Gramatzki M, Peipp M. Kellner C, et al. J Immunol Methods. 2011 Aug 31;371(1-2):122-33. doi: 10.1016/j.jim.2011.06.023. Epub 2011 Jun 30. J Immunol Methods. 2011. PMID: 21756911

See all similar articles

Cited by

Isolation of anti-CD22 Fv with high affinity by Fv display on human cells.
Ho M, Nagata S, Pastan I. Ho M, et al. Proc Natl Acad Sci U S A. 2006 Jun 20;103(25):9637-42. doi: 10.1073/pnas.0603653103. Epub 2006 Jun 8. Proc Natl Acad Sci U S A. 2006. PMID: 16763048 Free PMC article.
Treatment of hepatocellular carcinoma in a mouse xenograft model with an immunotoxin which is engineered to eliminate vascular leak syndrome.
Wang H, Song S, Kou G, Li B, Zhang D, Hou S, Qian W, Dai J, Tian L, Zhao J, Guo Y. Wang H, et al. Cancer Immunol Immunother. 2007 Nov;56(11):1775-83. doi: 10.1007/s00262-007-0321-4. Epub 2007 Apr 13. Cancer Immunol Immunother. 2007. PMID: 17431617 Free PMC article.
An evolved ribosome-inactivating protein targets and kills human melanoma cells in vitro and in vivo.
Cheung MC, Revers L, Perampalam S, Wei X, Kiarash R, Green DE, Abdul-Wahid A, Gariépy J. Cheung MC, et al. Mol Cancer. 2010 Feb 3;9:28. doi: 10.1186/1476-4598-9-28. Mol Cancer. 2010. PMID: 20128926 Free PMC article.
Development and scale-up of a commercial fed batch refolding process for an anti-CD22 two chain immunotoxin.
Linke T, Aspelund MT, Thompson C, Xi G, Fulton A, Wendeler M, Pabst TM, Wang X, Wang WK, Ram K, Hunter AK. Linke T, et al. Biotechnol Prog. 2014 Nov-Dec;30(6):1380-9. doi: 10.1002/btpr.1983. Epub 2014 Sep 2. Biotechnol Prog. 2014. PMID: 25139260 Free PMC article.
An update in the use of antibodies to treat glioblastoma multiforme.
Hernández-Pedro NY, Rangel-López E, Vargas Félix G, Pineda B, Sotelo J. Hernández-Pedro NY, et al. Autoimmune Dis. 2013;2013:716813. doi: 10.1155/2013/716813. Epub 2013 Nov 5. Autoimmune Dis. 2013. PMID: 24294521 Free PMC article. Review.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Other Literature Sources
- The Lens - Patent Citations Database